This market research report was developed based off of the responses of 177 industry professionals involved in outsourcing biologic projects, and the 365 service encounters they’ve had over the last 18 months. It includes information on respondent’s outsourcing philosophies and practices, their perceptions of and experiences with CMOs involved in biologic API, how they select contract manufacturers for specific projects, and their performance analysis specific to the large molecule offerings of several different CMOs.
CMO attributes evaluated in this report include: Ability to manufacture biologic API, Reliable on-time delivery, Regulatory history, Quality performance metrics, Scale-up and tech transfer abilities, Scientific knowledge, Right-first-time measurements, and many others.
Drug developers can use this report to find out which CMO attributes drive outsourcing partner selection for biologic API projects among their peers, make an educated purchase of contract manufacturer services, and see verbatim responses from respondents regarding their experience with CMOs. Ultimately, the information can help guide CMO selection for large molecule projects from early clinical stages to commercialization.
CMOs can use the report to better understand sponsors’ outsourcing preferences and practices for selecting a contract manufacturer for outsourced biologic manufacturing projects, compare their performance against their competitors specific to biologic API, and uncover industry perceptions of their organization’s strengths and weaknesses.
The report provides a Consumer Reports-style analysis where each of the 30 CMOs included in the research is evaluated across 27 service quality attributes, making this report the most comprehensive assessment of biologic API-specific CMO quality in the contract manufacturing space. These performance metrics are categorized into four ‘scorecards’: Delivery Factors, Organization Factors, Capabilities and Staff Characteristics. From these performance evaluations, respondents indicated how well the manufacturers performed with respect to expectations specific to their experience working with the manufacturer(s). For buyers of outsourced services, the report includes highly valuable information to help guide CMO selection for large molecule projects from early clinical stages to commercialization.
This market research report includes in-depth analysis of CMOs like AbbVie Contract Manufacturing, Boehringer Ingelheim, Catalent, Celltrion, CMC Biologics, FujiFilm Diosynth Biotechnologies, GSK Contract Manufacturing, KBI Biopharma, Lonza, Novasep, Patheon, Pfizer CentreOne, Samsung BioLogics, and more. Download the preview file for more information.